Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
September 7, 2016NeuroRx, a clinical-stage pharmaceutical company developing CycluradTM, a first-in-class, potentially breakthrough drug for the prevention of suicide in bipolar depression, announced today that it...
-
June 1, 2016Company with research operations in US and Israel seeks to develop first-in-class drug to decrease the risk of suicide in those suffering from depression
TEL AVIV, Israel - NeuroRx, a clinical-stage pharmaceutical company developing a first-in-class potentially breakthrough drug for the prevention of suicide in bipolar depression, was awarded first...
-
October 21, 2015Findings note the transient nature of ketamine effects and paucity of promising experimental NMDA antagonists
The active ingredient of Cyclurad™ by NeuroRx, Inc has been identified as potentially promising in the treatment of depression in this month's report by the American Psychiatric Association Task...
-
June 24, 2015Journal of Clinical Psychiatry publishes initial report of human study which showed 50% reduction in symptoms of depression and 75% reduction in suicidality
NeuroRx, Inc., a clinical phase pharmaceutical company, reports first-in-man efficacy data for a newly-purposed class of drugs targeted towards rapidly reducing symptoms of depression and...
-
June 24, 2013Include multimedia assets in your release for better visibility
Educating your customers and prospects by sharing expertise and insight is at the heart of content marketing. According to a recent article by Joe Pulizzi,...
Click here to view our corporate presentation or on the image below
 |
